Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A sarcoma that arises from the spinal cord.
Biomarker and diagnostic research for spinal cord sarcoma has been reported in the published literature.
No clinical trials have been registered for spinal cord sarcoma.
84 publications have been identified in PubMed for spinal cord sarcoma. Research spans Case Report / Case Series (45%), Basic Science / Preclinical (24%), and Review / Meta-Analysis (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 38 | 45% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 9:38 PM UTC
20 |
24% |
Research summaries | 14 | 17% |
Testing and diagnosis research | 3 | 4% |
Disease patterns and progression | 3 | 4% |
New treatment approaches | 3 | 4% |
Clinical study results | 2 | 2% |
Other research | 1 | 1% |
Bista B (2026). [PMID: 41492349](https://pubmed.ncbi.nlm.nih.gov/41492349/). *Radiol Case Rep*. [Case Report / Case Series]
Yi X (2026). [PMID: 40670295](https://pubmed.ncbi.nlm.nih.gov/40670295/). *Cell Prolif*. [Gene Therapy / Novel Therapeutics]
Tenny S (2026). [PMID: 28613596](https://pubmed.ncbi.nlm.nih.gov/28613596/). *Unknown Journal*. [Other]
Lejnieks M (2026). [PMID: 41566381](https://pubmed.ncbi.nlm.nih.gov/41566381/). *J Med Case Rep*. [Case Report / Case Series]
Adler A (2026). [PMID: 41666877](https://pubmed.ncbi.nlm.nih.gov/41666877/). *Clin Pract Cases Emerg Med*. [Case Report / Case Series]
Ichikawa T (2026). [PMID: 41884107](https://pubmed.ncbi.nlm.nih.gov/41884107/). *Radiol Case Rep*. [Case Report / Case Series]
Marcadet L (2026). [PMID: 40971894](https://pubmed.ncbi.nlm.nih.gov/40971894/). *Brain*. [Gene Therapy / Novel Therapeutics]
Ye R (2026). [PMID: 41521307](https://pubmed.ncbi.nlm.nih.gov/41521307/). *Neurol Sci*. [Case Report / Case Series]
Saliba T (2026). [PMID: 41438662](https://pubmed.ncbi.nlm.nih.gov/41438662/). *Radiol Case Rep*. [Case Report / Case Series]
Tauro A (2026). [PMID: 42137748](https://pubmed.ncbi.nlm.nih.gov/42137748/). *JFMS Open Rep*. [Case Report / Case Series]
AI-curated news mentioning spinal cord sarcoma
Updated Feb 9, 2026
A multicenter study by the Korean Society of Spinal Tumors evaluates the feasibility and oncologic outcomes of en bloc resection with intentional tumor transgression in primary spinal sarcoma. This research contributes to understanding surgical approaches in treating this rare cancer.